Arthur Tzianabos, President & CEO at Homology Medicines, Inc. (FIXX), sold 5,354 shares at $3.78 ($20K) on 2022-01-05, disclosed to the SEC on 2022-01-12.
Scheduled sale ($20k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FIXX | SELL | 2024-02-15 | $7K | — | Filing → |
| FIXX | SELL | 2023-01-11 | $15K | — | Filing → |
| STOK | SELL | 2021-02-23 | $607K | — | Filing → |